In Natus proxy fight, Glass Lewis supports Voce nominees

BOSTON (Reuters) – Influential proxy-advisory firm Glass Lewis & Co recommended that Natus Medical Incorporated shareholders remove two company nominated directors and replace them with hedge fund…